Jefferson A Bastidas, MD
General Surgery · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bastidas’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G77498 · Current
Licensed to practise in California · since 1993 · expires 2027-09-30 · University of Cincinnati College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$148,401
Medicare paid this office $148,401 for 230 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $12,075 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $10,200 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $8,695 | $66 |
| Removal of gallbladder with x-ray study of bile ducts using an endoscope | 15 | $8,016 | $534 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,600 | $110 |
See all 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $12,075 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $10,200 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $8,695 | $66 |
| Removal of gallbladder with x-ray study of bile ducts using an endoscope | 15 | $8,016 | $534 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,600 | $110 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 53 | $3,759 | $41 |
| New patient visit (60+ min) | 12 | $2,357 | $196 |
| Return visit (30+ min) | 16 | $2,093 | $116 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Coronary artery bypass graft (CABG) | 1-10 | None |
| Hernia repair - groin (open) | 15 | More than 94% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of the uterus | 1-10 | None |
| Removal of tissue | 12 | More than 63% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 12 | More than 44% of doctors who do this |
Who their Medicare patients are
230 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 23% · Women 52% · Also on Medicaid 31% · Health risk score 2.11. Above the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Diabetes 44% · Chronic kidney disease 43% · Coronary heart disease 40% · Cancer 30% · Atrial fibrillation 30% · Depression 30% · Heart failure 28% · COPD 20% · Dementia 20% · Stroke 16%.
The office billed $927,759, Medicare allowed $188,551 and paid $148,401; for 724 services of 112 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 230 | 724 | 77 | 2.11 | $927,759 | $148,401 |
| 2023 | 238 | 697 | 76 | 2.50 | $910,459 | $153,806 |
| 2022 | 257 | 843 | 76 | 1.86 | $1,092,579 | $189,115 |
| 2021 | 268 | 903 | 76 | 2.45 | $791,190 | $187,852 |
| 2020 | 244 | 894 | 76 | 1.84 | $1,461,176 | $218,003 |
| 2019 | 280 | 1,148 | 75 | 2.14 | $1,389,748 | $213,280 |
| 2018 | 292 | 1,141 | 75 | 1.95 | $983,136 | $205,612 |
| 2017 | 276 | 1,048 | 75 | 2.22 | $856,409 | $200,528 |
| 2016 | 286 | 1,142 | 74 | 2.57 | $814,892 | $193,455 |
| 2015 | 241 | 992 | 75 | 2.16 | $625,906 | $169,349 |
| 2014 | 331 | 1,421 | 75 | 1.95 | $876,632 | $235,923 |
| 2013 | 328 | 1,450 | 75 | 1.92 | $1,014,120 | $280,056 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $12,112 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $11,564 | $156 |
| Removal of gallbladder with x-ray study of bile ducts using an endoscope | 16 | $9,210 | $576 |
| Removal of gallbladder using an endoscope | 12 | $5,658 | $471 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 51 | $4,766 | $44 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,705 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,674 | $117 |
| Return visit (30+ min) | 20 | $2,813 | $122 |
| Short return visit (20+ min) | 14 | $1,652 | $87 |
2022: 10 services
| Removal of gallbladder with x-ray study of bile ducts using an endoscope | 17 | $10,680 | $628 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 87 | $9,320 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 64 | $7,765 | $121 |
| Repair of incisional or abdominal hernia | 15 | $6,222 | $415 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,173 | $178 |
| Return visit (30+ min) | 23 | $4,010 | $122 |
| Placement of mesh to repair incisional or abdominal hernia | 14 | $3,009 | $215 |
| Short return visit (20+ min) | 27 | $2,566 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $1,929 | $64 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 11 | $179 | $16 |
2021: 14 services
| Short return visit (20+ min) | 53 | $7,660 | $86 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 80 | $7,347 | $34 |
| Removal of gallbladder with x-ray study of bile ducts using an endoscope | 13 | $7,290 | $561 |
| Return visit (30+ min) | 41 | $6,972 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,311 | $180 |
| New patient visit (60+ min) | 24 | $4,921 | $205 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,711 | $124 |
| New patient visit (45+ min) | 25 | $4,023 | $161 |
| Emergency department visit with high level of medical decision making | 22 | $3,390 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $2,779 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $1,954 | $93 |
| Emergency department visit with moderate level of medical decision making | 16 | $1,725 | $108 |
| Short return visit | 15 | $1,063 | $53 |
| New patient visit (30+ min) | 12 | $1,016 | $85 |
2020: 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,577 | $179 |
| Removal of gallbladder with x-ray study of bile ducts using an endoscope | 13 | $6,643 | $511 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 66 | $5,477 | $35 |
| Return visit (30+ min) | 48 | $5,444 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $5,370 | $65 |
| New patient visit (60+ min) | 25 | $4,778 | $191 |
| Short return visit (20+ min) | 35 | $3,894 | $68 |
| Repair of abdomen using abdominal lining graft | 11 | $3,426 | $311 |
| Insertion of central venous tube with port (5 years or older) | 11 | $3,397 | $309 |
| Long return visit (40+ min) | 22 | $3,350 | $140 |
| Emergency department visit with high level of medical decision making | 22 | $3,038 | $138 |
| New patient visit (45+ min) | 18 | $2,799 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,193 | $91 |
| Emergency department visit with low level of medical decision making | 19 | $965 | $51 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 11 | $185 | $17 |
2019: 14 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $9,724 | $174 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 82 | $9,112 | $33 |
| Return visit (30+ min) | 66 | $8,467 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $7,556 | $62 |
| New patient visit (60+ min) | 34 | $6,235 | $183 |
| Insertion of central venous tube with port (5 years or older) | 16 | $4,648 | $291 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $4,409 | $88 |
| Removal of gallbladder with x-ray study of bile ducts using an endoscope | 11 | $4,261 | $387 |
| Long return visit (40+ min) | 23 | $3,795 | $126 |
| Short return visit (20+ min) | 40 | $3,266 | $62 |
| Emergency department visit with low level of medical decision making | 47 | $2,564 | $50 |
| Placement of mesh to repair incisional or abdominal hernia | 13 | $2,486 | $191 |
| Therapy procedure using a special bandage, vacuum pump and disposable medical equipment, surface area 50.0 sq cm or less | 17 | $389 | $22 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 16 | $254 | $16 |
2018: 16 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $11,890 | $167 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 104 | $8,258 | $33 |
| Return visit (30+ min) | 53 | $7,025 | $95 |
| Removal of gallbladder using an endoscope | 13 | $5,739 | $441 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $5,696 | $61 |
| Short return visit (20+ min) | 40 | $3,918 | $64 |
| New patient visit (60+ min) | 22 | $3,837 | $174 |
| Insertion of central venous tube with port (5 years or older) | 11 | $3,144 | $286 |
| Long return visit (40+ min) | 17 | $2,954 | $128 |
| Emergency department visit with low level of medical decision making | 52 | $2,762 | $49 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,203 | $88 |
| New patient visit (45+ min) | 15 | $2,161 | $144 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,725 | $108 |
| Emergency department visit with straightforward medical decision making | 12 | $314 | $26 |
| Therapy procedure using a special bandage, vacuum pump and disposable medical equipment, surface area 50.0 sq cm or less | 14 | $296 | $21 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 13 | $202 | $16 |
2017: 11 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $12,407 | $170 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 88 | $8,639 | $34 |
| New patient visit (60+ min) | 32 | $5,704 | $178 |
| Removal of gallbladder using an endoscope | 13 | $5,431 | $418 |
| Return visit (30+ min) | 44 | $5,427 | $95 |
| Long return visit (40+ min) | 25 | $4,727 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $4,713 | $63 |
| Short return visit (20+ min) | 49 | $4,699 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,498 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $2,630 | $91 |
| New patient visit (45+ min) | 17 | $2,303 | $135 |
2016: 10 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $12,701 | $176 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 106 | $12,612 | $34 |
| Removal of gallbladder using an endoscope | 20 | $7,935 | $397 |
| Return visit (30+ min) | 41 | $6,512 | $94 |
| New patient visit (60+ min) | 25 | $4,641 | $186 |
| Long return visit (40+ min) | 32 | $4,458 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $4,159 | $63 |
| Short return visit (20+ min) | 41 | $3,735 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,363 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,359 | $91 |
2015: 10 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 83 | $8,946 | $35 |
| Short return visit (20+ min) | 51 | $6,065 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $5,699 | $121 |
| Return visit (30+ min) | 33 | $5,151 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,067 | $181 |
| Removal of gallbladder using an endoscope | 11 | $4,454 | $405 |
| New patient visit (60+ min) | 24 | $4,444 | $185 |
| Long return visit (40+ min) | 19 | $2,977 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,202 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,304 | $93 |
2014: 13 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 148 | $16,951 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 69 | $8,486 | $121 |
| New patient visit (60+ min) | 37 | $6,736 | $182 |
| Short return visit (20+ min) | 58 | $6,266 | $67 |
| Removal of gallbladder using an endoscope | 16 | $5,694 | $356 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,134 | $177 |
| Return visit (30+ min) | 29 | $4,303 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $3,779 | $64 |
| Short return visit | 40 | $2,781 | $39 |
| Long return visit (40+ min) | 17 | $2,136 | $126 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,637 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,574 | $87 |
| New patient visit (30+ min) | 13 | $1,182 | $91 |
2013: 19 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 144 | $14,875 | $34 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 75 | $8,778 | $117 |
| Partial removal of small bowel with reconnection | 12 | $7,586 | $584 |
| Short return visit (20+ min) | 70 | $7,531 | $65 |
| Repair of incisional or abdominal hernia | 11 | $4,019 | $309 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,941 | $171 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 39 | $3,646 | $87 |
| New patient visit (60+ min) | 20 | $3,614 | $181 |
| Repair of abdomen using abdominal lining graft | 12 | $3,433 | $245 |
| Return visit (30+ min) | 29 | $3,207 | $100 |
| Short return visit | 49 | $2,854 | $41 |
| Insertion of stomach tube using a flexible endoscope | 12 | $2,687 | $224 |
| Long return visit (40+ min) | 14 | $2,511 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,126 | $63 |
| New patient visit (30+ min) | 21 | $2,066 | $98 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,865 | $64 |
| New patient visit (45+ min) | 12 | $1,812 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,617 | $90 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 11 | $176 | $16 |
Drugs they prescribed that Part D paid
$19,002
Pharmacies billed $19,002 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 41% of their Part D prescriptions (39 of 96) in 2024. Above the middle of the specialty; the typical general surgery clinician is at 34%.
79 generic and 17 brand-name prescriptions · $19,002 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydromorphone | 15 | $6,733 | $449 |
| Hydrocodone-Acetaminophen | 18 | $98 | $5 |
| Furosemide | 11 | $25 | $2 |
Year by year
| 2024 | 96 | 33 | 41% (39) | 18% | $19,002 |
| 2023 | 88 | 38 | 39% (34) | 28% | $39,700 |
| 2022 | 103 | 36 | 38% (39) | 12% | $26,025 |
| 2021 | 114 | 35 | 32% (36) | None | $17,778 |
| 2020 | 112 | 30 | 28% (31) | 19% | $19,693 |
| 2019 | 88 | 33 | 30% (26) | None | $7,109 |
| 2018 | 64 | 27 | 31% (20) | 23% | $13,424 |
| 2017 | 94 | 39 | 45% (42) | None | $3,473 |
| 2016 | 61 | 32 | 54% (33) | None | $3,679 |
| 2015 | 106 | 40 | 27% (29) | 27% | $21,178 |
| 2014 | 161 | 55 | 24% (39) | 34% | $41,174 |
| 2013 | 177 | 48 | 25% (45) | 28% | $33,732 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Creon | 13 | $14,478 | $1,114 |
| Hydromorphone | 14 | $8,111 | $579 |
| Hydrocodone-Acetaminophen | 14 | $108 | $8 |
2022: 4 drugs
| Hydromorphone | 11 | $10,550 | $959 |
| Creon | 11 | $10,456 | $951 |
| Cholestyramine | 14 | $1,015 | $73 |
| Hydrocodone-Acetaminophen | 25 | $206 | $8 |
2021: 3 drugs
| Hydromorphone | 15 | $7,658 | $511 |
| Omeprazole | 13 | $168 | $13 |
| Hydrocodone-Acetaminophen | 19 | $114 | $6 |
2020: 5 drugs
| Creon | 15 | $12,516 | $834 |
| Hydromorphone | 13 | $3,315 | $255 |
| Diphenoxylate-Atropine | 12 | $1,287 | $107 |
| Omeprazole | 11 | $165 | $15 |
| Hydrocodone-Acetaminophen | 15 | $63 | $4 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 14 | $57 | $4 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 18 | $159 | $9 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 36 | $332 | $9 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 26 | $300 | $12 |
2015: 2 drugs
| Creon | 25 | $19,230 | $769 |
| Hydrocodone-Acetaminophen | 23 | $206 | $9 |
2014: 3 drugs
| Creon | 41 | $36,256 | $884 |
| Hydrocodone-Acetaminophen | 24 | $443 | $18 |
| Pantoprazole | 23 | $167 | $7 |
2013: 4 drugs
| Creon | 31 | $22,993 | $742 |
| Hydrocodone-Acetaminophen | 31 | $334 | $11 |
| Famotidine | 14 | $213 | $15 |
| Pantoprazole | 13 | $109 | $8 |
Money from drug and device companies
$2,454 in 2025
| 2025 | 7 | 20 | None | $2,454 |
| 2024 | 6 | 20 | None | $3,349 |
| 2023 | 6 | 21 | None | $2,027 |
| 2022 | 8 | 14 | None | $2,365 |
| 2021 | 1 | 1 | $825 | $825 |
| 2020 | 8 | 11 | None | $706 |
| 2019 | 8 | 17 | None | $1,623 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Histosonics | None | $1,396 | 1 payment
|
| Smith+Nephew | Grafix | $507 | 6 payments
|
| Vertex Pharmaceuticals | Journavx | $203 | 4 payments
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $125 | 1 payment
|
| Biotissue Holdings | None | $107 | 1 payment
|
| Ethicon US | Echelon; Endopath | $80 | 2 payments
|
See all 16 published payments
| Vertex Pharmaceuticals | Meals · 2025-11-19 | Journavx | $125 |
| Vertex Pharmaceuticals | Meals · 2025-11-18 | Journavx | $30 |
| Smith+Nephew | Meals · 2025-10-30 | Grafix Pl | $111 |
| Smith+Nephew | Meals · 2025-09-18 | Oasis | $36 |
| Ethicon US | Meals · 2025-08-28 | Echelon; Endopath | $44 |
| Smith+Nephew | Meals · 2025-08-02 | Stravix | $24 |
| TELA Bio | Meals · 2025-06-25 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $125 |
| Integra LifeSciences | Meals · 2025-06-24 | Integra | $36 |
| Smith+Nephew | Meals · 2025-06-10 | Stravix | $47 |
| Vertex Pharmaceuticals | Meals · 2025-05-20 | Journavx | $20 |
| Smith+Nephew | Meals · 2025-05-16 | Collagenase Santyl | $141 |
| Histosonics | Travel · 2025-05-14 | None | $1,396 |
| Smith+Nephew | Meals · 2025-05-14 | Grafix | $148 |
| Ethicon US | Meals · 2025-05-13 | Enseal | $36 |
| Vertex Pharmaceuticals | Meals · 2025-03-06 | Journavx | $28 |
| Biotissue Holdings | Meals · 2025-01-21 | None | $107 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,349
| Biotissue Holdings | None | $1,654 | 9 payments
|
| Medical Device Business Services | Enseal | $1,475 | 6 payments
|
| Biocomposites | Stimulan | $96 | 1 payment
|
| Ethicon US | Harmonic | $75 | 2 payments
|
| TriSalus Life Sciences | Trinav Infusion System | $30 | 1 payment
|
| TELA Bio | Ovitex 2s | $19 | 1 payment
|
2023: $2,027
| Davol | Phasix Mesh | $1,007 | 15 payments
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $703 | 2 payments
|
| Lexington Medical | Aeon Endostapler & Echelon Flex Powered Stapler | $121 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $119 | 1 payment
|
| Rti Surgical | Cortiva Allograft Dermis | $41 | 1 payment
|
| Ethicon | Echelon Flex | $37 | 1 payment
|
2022: $2,365
| Musculoskeletal Transplant Foundation | None | $1,795 | 6 payments
|
| BioTissue Holdings | Neox | $174 | 1 payment
|
| Heron Therapeutics | Zynrelef | $118 | 1 payment
|
| Ethicon US | Echelon Endopath | $96 | 2 payments
|
| Access Pro Medical | Matriderm | $89 | 1 payment
|
| Integra LifeSciences | Surgimend | $36 | 1 payment
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $32 | 1 payment
|
| Davol | Phasix Mesh | $25 | 1 payment
|
2021: $825
| RTI Surgical | Fortiva Porcine Dermis | $825 | 1 payment
|
2020: $706
| Intuitive Surgical | Da Vinci Surgical System | $191 | 2 payments
|
| Medical Device Business Services | Stratafix | $125 | 1 payment
|
| Baxter Healthcare | Renal - Pd | $120 | 1 payment
|
| TELA Bio | Ovitex | $114 | 2 payments
|
| Acell | None | $99 | 2 payments
|
| Davol | Phasix | $24 | 1 payment
|
| Terumo Cardiovascular Systems | Capiox | $20 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $14 | 1 payment
|
2019: $1,623
| Acell | None | $956 | 7 payments
|
| Davol | Phasix | $284 | 3 payments
|
| TELA Bio | Ovitex | $131 | 1 payment
|
| Mallinckrodt Enterprises | Ofirmev | $121 | 1 payment
|
| Ethicon US | Enseal Product Family | $47 | 2 payments
|
| Prescient Surgical | Cleancision | $42 | 1 payment
|
| Janssen Biotech | Erleada | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $20 | 1 payment
|
Professional record
- NPI
- 1609808195
- Licence
- CA G77498California G77498: Current · expires 2027-09-30
- Trained
- University of Cincinnati College of Medicine, 1985
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Surgery (208600000X); Surgical oncology (2086X0206X)
- Mailing address
- 14981 National Ave Ste 4, Los Gatos, CA, 95032
- NPI first listed
- 2006-07-07
- NPI last updated
- 2016-11-18
This is when the NPI record was last certified, not a medical board exam.